touchIMMUNOLOGY were delighted to speak with our expert faculty member Prof. Marcus Maurer (Charité – Universitätsmedizin Berlin, Germany) to learn more around our new society partner UCARE, the Urticaria Center of Reference and Excellence, to discuss raising awareness around urticaria, the current initiatives in place to increase physician and patient knowledge around urticaria and the challenges associated with diagnosis and management of urticaria and what UCARE is doing to overcome these.
Questions
- Could you tell us a little about UCARE and its objectives? (0:43)
- Which achievements are you most proud of in the last year? (1:38)
- What are your priorities for the year ahead? (2:37)
- What do you consider the most challenging aspects of the diagnosis and management of urticaria? (3:26)
- Could you tell us a little about your current and upcoming projects? (4:19)
Disclosures: Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Allerdia, Amgen, Aralez, ArgenX, AstraZeneca, Celldex, Centogene, CSL Behring, FAES, Genentech, GIInnovation, Innate Pharma, Kyowa Kirin, Leo Pharma, Lilly, Menarini, Moxie, Novartis, Pfizer, Roche, Sanofi/Regeneron, Third HarmonicBio, UCB, and Uriach.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
